TY - JOUR
T1 - Electronic Nose Sensor Drift Affects Diagnostic Reliability and Accuracy of Disease-Specific Algorithms
AU - Bosch, Sofie
AU - de Menezes, Renée X.
AU - Pees, Suzanne
AU - Wintjens, Dion J.
AU - Seinen, Margien
AU - Bouma, Gerd
AU - Kuyvenhoven, Johan
AU - Stokkers, Pieter C. F.
AU - de Meij, Tim G. J.
AU - de Boer, Nanne K. H.
N1 - Funding Information: S Bosch has nothing to declare. R Menezes has nothing to declare. S Pees has nothing to declare. D Wintjens has nothing to declare. M Seinen has nothing to declare. G Bouma has nothing to declare. P Stokkers has nothing to declare. J Kuijvenhoven has served as a consultant for Janssen Pharmaceuticals. TGJ de Meij has served as a speaker for Mead Johnson. He has received a (unrestricted) research grant from Danone. NKH de Boer has served as a speaker for AbbVie and MSD. He has served as consultant and principal investigator for TEVA Pharma BV and Takeda. He has received a (unrestricted) research grant from Falk, MLDS and Takeda. Publisher Copyright: © 2022 by the authors.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Sensor drift is a well-known disadvantage of electronic nose (eNose) technology and may affect the accuracy of diagnostic algorithms. Correction for this phenomenon is not routinely performed. The aim of this study was to investigate the influence of eNose sensor drift on the development of a disease-specific algorithm in a real-life cohort of inflammatory bowel disease patients (IBD). In this multi-center cohort, patients undergoing colonoscopy collected a fecal sample prior to bowel lavage. Mucosal disease activity was assessed based on endoscopy. Controls underwent colonoscopy for various reasons and had no endoscopic abnormalities. Fecal eNose profiles were measured using Cyranose 320 ®. Fecal samples of 63 IBD patients and 63 controls were measured on four subsequent days. Sensor data displayed associations with date of measurement, which was reproducible across all samples irrespective of disease state, disease activity state, disease localization and diet of participants. Based on logistic regression, corrections for sensor drift improved accuracy to differentiate between IBD patients and controls based on the significant differences of six sensors (p = 0.004; p < 0.001; p = 0.001; p = 0.028; p < 0.001 and p = 0.005) with an accuracy of 0.68. In this clinical study, short-term sensor drift affected fecal eNose profiles more profoundly than clinical features. These outcomes emphasize the importance of sensor drift correction to improve reliability and repeatability, both within and across eNose studies.
AB - Sensor drift is a well-known disadvantage of electronic nose (eNose) technology and may affect the accuracy of diagnostic algorithms. Correction for this phenomenon is not routinely performed. The aim of this study was to investigate the influence of eNose sensor drift on the development of a disease-specific algorithm in a real-life cohort of inflammatory bowel disease patients (IBD). In this multi-center cohort, patients undergoing colonoscopy collected a fecal sample prior to bowel lavage. Mucosal disease activity was assessed based on endoscopy. Controls underwent colonoscopy for various reasons and had no endoscopic abnormalities. Fecal eNose profiles were measured using Cyranose 320 ®. Fecal samples of 63 IBD patients and 63 controls were measured on four subsequent days. Sensor data displayed associations with date of measurement, which was reproducible across all samples irrespective of disease state, disease activity state, disease localization and diet of participants. Based on logistic regression, corrections for sensor drift improved accuracy to differentiate between IBD patients and controls based on the significant differences of six sensors (p = 0.004; p < 0.001; p = 0.001; p = 0.028; p < 0.001 and p = 0.005) with an accuracy of 0.68. In this clinical study, short-term sensor drift affected fecal eNose profiles more profoundly than clinical features. These outcomes emphasize the importance of sensor drift correction to improve reliability and repeatability, both within and across eNose studies.
KW - diagnostic
KW - electronic nose
KW - inflammatory bowel disease
KW - sensor drift
KW - volatile organic compounds
UR - http://www.scopus.com/inward/record.url?scp=85143817088&partnerID=8YFLogxK
U2 - https://doi.org/10.3390/s22239246
DO - https://doi.org/10.3390/s22239246
M3 - Article
C2 - 36501947
SN - 1424-8220
VL - 22
JO - Sensors (Basel, Switzerland)
JF - Sensors (Basel, Switzerland)
IS - 23
M1 - 9246
ER -